Skip links

Vowst™ (fecal microbiota spores live-brpk)

Full Name Vowst™ (fecal microbiota spores live-brpk)
Drug Vowst
Manufacturer Aimmune Therapeutics
Route of Administration Oral
Site of Care Home
Approved Indication Prevent the recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older following antibacterial treatment for recurrent CDI (rCDI)
Disease Recurrent C. difficile Infection (rCDI)
Therapeutic Area Infectious Disease; Gastroenterology
Enrollment Form Link Vowst Enrollment Form
Phone Number 800-485-4885
Fax Number 877-640-5179
Product Website vowsthcp.com